(IN BRIEF) Fresenius, a global healthcare group, has appointed an independent advisory board to focus on sustainability issues. Comprising four experts from various fields, the board will support the development of Fresenius’ sustainability strategy. This move reflects Fresenius’ commitment to … Read the full press release
Posted in Business, Energy, Gas & Oil, Environment, Germany, Healthcare, Industrial, Management, Technology
Tagged Anahita Thoms, Atlantik-Brücke, Baker McKenzie, Dr. Bibi Hahn, ESG, ESG Advisory Board, Fabian Kienbaum, Fiona Adshead, Michael Moser, Michael Sen, Prof. Judith Walls, sustainability strategy, The Fresenius healthcare group, UNICEF Germany, University of St. Gallen
(IN BRIEF) trinamiX GmbH debuts its latest innovation, the Consumer Spectroscopy solution, at the Mobile World Congress in Barcelona. This cutting-edge technology integrates a near-infrared (NIR) spectrometer into a smartphone reference design powered by Qualcomm’s Snapdragon® 8 Gen 3 platform, … Read the full press release
Posted in Business, Financial, Germany, Healthcare, Industrial, Investment, Management, Media, News, Technology, Telecom
Tagged BASF, Judd Heape, LUMILEDS, MWC Barcelona 2024, partnership, Qualcomm, Revea, Spectroscopy Solution, trinamiX, Troels Marstrand, Viavi, Wilfried Hermes
(IN BRIEF) Voydeya (danicopan), a first-in-class oral Factor D inhibitor, has been recommended for marketing authorization in the European Union (EU) as an add-on to ravulizumab or eculizumab for adult patients with paroxysmal nocturnal haemoglobinuria (PNH) who experience residual haemolytic … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged Adrian Kemp, AstraZeneca, eculizumab, Marc Dunoyer, PNH, Professor Hubert Schrezenmeier, ravulizumab, safety, treatment, Voydeya
(IN BRIEF) GSK plc has announced positive headline results from the pivotal EAGLE-1 phase III trial for gepotidacin, an oral antibiotic aimed at treating uncomplicated urogenital gonorrhoea in adolescents and adults. The trial demonstrated gepotidacin’s non-inferiority compared to the current … Read the full press release
(IN BRIEF) Grenada’s healthcare infrastructure is set to undergo a significant transformation with a US$ 9,970,500 loan from the Caribbean Development Bank (CDB), financed by the European Investment Bank (EIB). The project, launched in St. George’s, Grenada, aims to strengthen … Read the full press release
Posted in Banks, Business, Economy, Financial, Government, Healthcare, Industrial, Infrastructure & Utilities, Investment, Luxembourg, Management, News
Tagged Caribbean Development Bank (CDB), EIB Dr Martin Baptiste, Grenada, Healthcare, Kristina Eisele, Malgorzata Wasilewksa, partnership, Philip A. Telesford
(IN BRIEF) Boehringer Ingelheim has reported compelling results from its Phase II trial of Survodutide, a novel glucagon/GLP-1 receptor dual agonist, indicating its potential to become a leading treatment for Metabolic Dysfunction-Associated Steatohepatitis (MASH). In the trial, up to 83.0% … Read the full press release
Posted in Business, Education, Financial, Germany, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Boehringer Ingelheim, Carinne Brouillon, Dr. Arun Sanyal, MASH, Phase II Trial, Survodutide, treatment
(IN BRIEF) The University of Oxford and ZEISS have inaugurated the Oxford-ZEISS Centre of Excellence in Biomedical Imaging, promising cutting-edge microscopy and imaging technologies to further research in global health and disease. This collaboration between the Kennedy Institute of Rheumatology, … Read the full press release
Posted in Business, Electronics & Machinery, Environment, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged Biomedical Imaging, Dr. Bernhard Zimmermann, partnership, Professor Irene Tracey, Professor Marco Fritzsche, Professor Paul Riley, sustainability, University of Oxford, ZEISS
(IN BRIEF) A recent comprehensive review published in The Lancet Regional Health Europe offers insights into the risk factors and management strategies for atrial fibrillation (AF), a prevalent heart rhythm disorder affecting millions globally. Conducted by researchers from the University … Read the full press release
Posted in Business, Education, Environment, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged atrial fibrillation, Dr Eduard Shantsila, Management, Professor Deirdre Lane, Professor Gregory Lip, risk factors, Seoul National University College of Medicine, The Lancet, University of Liverpool
(IN BRIEF) ETZ hospital has finalized a €115 million financing deal with the European Investment Bank (EIB) and BNG Bank to support the modernization of its St. Elisabeth location in Tilburg. This funding will facilitate the construction of a new … Read the full press release
Posted in Banks, Business, Construction, Environment, Financial, Government, Healthcare, Industrial, Infrastructure & Utilities, Investment, Luxembourg, Management, Netherlands, News, Technology
Tagged BNG Bank, EIB, ETZ Hospital, Gerard van Berlo, Healthcare, modernization, Netherlands, partnership, Rob Schreppers, Robert de Groot, sustainability
(IN BRIEF) Europe has made significant progress in quantum computing with investments, partnerships, and innovations. Highlights include a €3.5 million investment in LioniX International by the University of Twente, and T-Systems offering cloud access to IBM’s quantum systems. Other developments … Read the full press release
Posted in Artificial Intelligence (AI), Automotive, Aviation & Aerospace, Belgium, Defence, Education, Electronics & Machinery, Energy, Gas & Oil, European Union, Finland, France, Germany, Healthcare, Internet & Online, Investment, Netherlands, News, Science, Security & Safety, Technology, Telecom, United Kingdom
Tagged 5G networks, 6G, AI, Airbus, Aleph Alpha, Anaqor AG, ASML, BMW Group, Bosch Ventures, Cybersecurity, cybersecurity readiness against quantum threats, Deutsche Telekom, diamond-based quantum bits, Eindhoven University of Technology, Eviden, Fraunhofer-Gesellschaft, Fujitsu, generative AI, IBM, Infineon Technologies, IQM Quantum Computers, LioniX, Mobile World Congress, Nostradamus, photonic quantum computing, plasma physics, Post-Quantum Algorithms, Post-quantum cryptography, post-quantum era, Quantinuum, quantum algorithms, quantum computers, quantum computing, quantum computing hardware, quantum computing-era security, quantum simulations, quantum solutions for machine learning, quantum technologies, quantum threats, quantum-inspired algorithms, QuTech, scalable quantum computers, semiconductor lithography, SK Telecom, solving complex problems, T-Systems, Thales, The European Commission, TiC6G, TRUSTECH 2023, ultra-cold electronic circuits, University of Glasgow, University of Twente
(IN BRIEF) Novo Nordisk A/S has announced the date for its Annual General Meeting, scheduled for Thursday, March 21, 2024, at 14:00 CET. The meeting will be held partially electronically, allowing shareholders to participate either in person at Bella Center … Read the full press release
Posted in Business, Denmark, Healthcare, Industrial, Management, Media, News, Pharma & Biotech, Science, Technology
Tagged Andreas Fibig, appointments, Board Re-election, Christina Law, Helge Lund, Henrik Poulsen, Kasim Kutay, Laurence Debroux, leadership, Martin Mackay, Novo Nordisk, Sylvie Grégoire
(IN BRIEF) In 2024, the University of Bristol’s Veterinary School commemorates 75 years of excellence in educating veterinary professionals and spearheading advancements in veterinary science. Established in 1949 following recommendations from the Loveday Committee, the school has evolved into a … Read the full press release
Posted in Business, Education, Environment, Financial, Healthcare, Industrial, Management, News, Science, Technology, United Kingdom
Tagged 75 years, Bristol Veterinary School, leadership, Professor Jeremy Tavaré, Queen Camilla, sustainability, Thomas Loveday, Tim Parkin, University of Bristol, Veterinary Medicine and Conservation
(IN BRIEF) Fresenius had a strong finish in 2023, with a robust fourth quarter performance. They project accelerated earnings growth in 2024 due to the momentum from their #FutureFresenius initiatives. Achieving their raised outlook for FY/23, the company saw continued … Read the full press release
(IN BRIEF) Wouter Witteman, a master’s student in Embedded Systems at Eindhoven University of Technology (TU/e), is known for his innovative solutions. His latest venture, SUWEVE, aims to improve wheelchair mobility by allowing users to face backward while being pushed. … Read the full press release
(IN BRIEF) Evonik has partnered with the University of Mainz to commercialize a new class of polyethylene glycols (PEGs) called randomized polyethylene glycols (rPEGs). These rPEGs will be integrated into Evonik’s specialized lipid platform for drug delivery in nucleic acid-based … Read the full press release
Posted in Chemicals, Germany, Healthcare, Pharma & Biotech, Science, Technology
Tagged Evonik, immunogenicity, lipid, lipid nanoparticle carriers, lipids, LNP carriers, nucleic acid delivery, nucleic acid-based medicines, PEGs, Polyethylene glycols, polymers, Prof. Dr. Holger Frey, randomized polyethylene glycols, rPEG lipids, rPEG-lipids, rPEGs, specialty chemicals, Thomas Riermeier, University of Mainz
(IN BRIEF) Royal Philips, a prominent player in health technology, proposes the re-appointment of Chairman Feike Sijbesma and Peter Löscher to its Supervisory Board, along with the appointment of Benoît Ribadeau-Dumas as a new member. The nominations, to be voted … Read the full press release
(IN BRIEF) In response to the latest UCAS data indicating a decline in applications for medicine, nursing, and midwifery courses, leaders from various higher education groups are urging the government to establish a ministerial taskforce. This taskforce would facilitate collaboration … Read the full press release
Posted in Business, Education, Government, Healthcare, Management, News, Science, Technology, United Kingdom
Tagged Council of Deans of Health, Dr Diana Beech, Gordon McKenzie, GuildHE, Healthcare Course Applications, Higher Education Leaders, Joanna Burton, London Higher, medicine, Midwifery, Million Plus, Nursing, partnership, Rachel Hewitt, Russell Group of Universities, Taskforce, UCAS, University Alliance, Vanessa Wilson
(IN BRIEF) AstraZeneca and Daiichi Sankyo’s Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted by the FDA for the treatment of locally advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC) in patients who have undergone prior … Read the full press release
Posted in Business, Education, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged Adrian Kemp, AstraZeneca, Daiichi Sankyo, datopotamab deruxtecan, Ken Takeshita, NSCLC Treatment, partnership, Susan Galbraith, sustainability
(IN BRIEF) AstraZeneca’s Tagrisso (osimertinib) demonstrates significant improvement in progression-free survival (PFS) for patients with unresectable, Stage III EGFR-mutated non-small cell lung cancer (NSCLC) after chemoradiotherapy (CRT) in the LAURA Phase III trial. The trial, led by Dr. Suresh Ramalingam, … Read the full press release
(IN BRIEF) AstraZeneca’s Tagrisso receives FDA approval for treating adult patients with locally advanced or metastatic EGFR-mutated non-small cell lung cancer (NSCLC) following a Priority Review. The decision is based on FLAURA2 Phase III trial results demonstrating that Tagrisso plus … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged Adrian Kemp, AstraZeneca, chemotherapy, Dave Fredrickson, EGFR-mutated lung cancer, FDA, Laurie Ambrose, Pasi A. Jänne, Tagrisso
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?